Representative of the Presidential Headquarters for Biotechnology Development Visits Cancer Research Center

According to the Public Relations Office of the Vice Chancellor for Research and Technology at Semnan University of Medical Sciences, a joint meeting was held as part of the University's strategic efforts to advance scientific development and strengthen technology-driven collaboration in the health sector. The meeting brought together officials from the Vice Chancellor for Research and Technology, a representative of the Presidential Headquarters for Biotechnology Development, and representatives of the Rah-e Aseman Foundation of Semnan.

The meeting was attended by Dr. Majid Eslami, Vice Chancellor for Research and Technology, accompanied by members of the University's management team; Dr. Ataollahi, representative of the Presidential Headquarters for Biotechnology Development; and Dr. Naderi and Mr. Sedighi, representatives of the Rah-e Aseman Foundation.

During the meeting, participants were introduced to the Cancer Research Center, its collaborating faculty members, research infrastructure and laboratory facilities, as well as the Foundation's support provided under the existing memorandum of understanding. The University also presented its request for financial support and research grants from the Presidential Headquarters for Biotechnology Development, which was reviewed and discussed.

On the sidelines of the meeting, the delegation visited the University's Cancer Research Center, the Comprehensive Cancer Diagnostic Center, and the Rah-e Aseman Foundation to evaluate their research infrastructure and specialized equipment as part of the mission assessment process for the design and production of an immunotherapy vaccine. The visit was conducted in the presence of Dr. Rasoul Baharloo, Head of the Cancer Research Center, and members of the Center's academic staff.

During the site visit, participants toured advanced research laboratories, reviewed the Center's scientific achievements, and were briefed on the latest biotechnology projects and innovative approaches to cancer diagnosis and treatment. Dr. Eslami emphasized the importance of translating laboratory research into practical healthcare products and highlighted the commercialization of scientific achievements as a key objective of these collaborative initiatives.

The meeting concluded with discussions on establishing support mechanisms for technology-based research projects and expanding collaboration among the Vice Chancellor for Research and Technology, the Cancer Research Center, and the Rah-e Aseman Foundation. Participants expressed their commitment to strengthening cooperation among these institutions in order to enhance healthcare services and promote the advancement of biotechnology in the region.